Alginates: From the ocean to gastroesophageal reflux disease treatment
Alginate-based pharmaceutical formulations have been successfully used to treat the symptoms of gastroesophageal reflux disease (GERD) for decades and have a rapid onset of symptom relief.
In the last twenty years, the knowledge and awareness of GERD has grown from the classical reflux symptoms of heartburn and regurgitation to the symptoms of extraesophageal reflux (EER), also known as airway reflux, silent reflux and laryngopharyngeal reflux disease (LPR).
This increased awareness has led to a far greater understanding of the reflux of gastric contents in the airways, lungs, and ears, leading to a myriad of additional ear, nose, and throat (ENT) and respiratory symptoms, which we now know may be indications for the use of alginate-based pharmaceutical products.
Research and clinical studies have demonstrated that upwards of 40% to 60% of Western populations can benefit from alginate-based products, and this benefit is quickly growing in other regions of the world where reflux disease is now recognized as a real and growing problem. Download the full paper here: Alginates- From the ocean to gastroesophageal reflux disease treatment